Twist Bioscience Executive Executes Tax-Related Stock Sale Amid Mixed Fiscal Results
Patrick John Finn, who serves as the President and Chief Operating Officer of Twist Bioscience Corp (NASDAQ:TWST), has completed a sale of company stock totaling approximately $162,531. The transaction, which took place on May 4, 2026, involved the disposal of 2,844 shares of common stock at a price point of $57.1488 per share.While insider selling…